Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 03, 2022

SELL
$0.97 - $3.08 $7,760 - $24,640
-8,000 Closed
0 $0
Q1 2022

Apr 29, 2022

BUY
$2.55 - $5.23 $20,400 - $41,840
8,000 New
8,000 $23,000
Q4 2021

Feb 03, 2022

SELL
$4.43 - $8.33 $68,199 - $128,240
-15,395 Closed
0 $0
Q3 2021

Oct 18, 2021

BUY
$6.07 - $9.89 $93,447 - $152,256
15,395 New
15,395 $112,000

Others Institutions Holding MGTA

About Magenta Therapeutics, Inc.


  • Ticker MGTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,890,500
  • Description
  • Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 antibody that targets hematopoietic stem cells (HSCs) and genetically mutated stem cells that ca...
More about MGTA
Track This Portfolio

Track Nisa Investment Advisors, LLC Portfolio

Follow Nisa Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.